T1	Participants 15 35	children with autism
T2	Participants 200 220	children with autism
T3	Participants 322 342	children with autism
T4	Participants 477 719	We conducted a randomized, double-blind, placebo-controlled trial with 40 consecutive children with autism, whose ages ranged from 2 to 9 years, who were receiving either risperidone or placebo given orally at a dose of 1 mg/day for 6 months.
T5	Participants 922 942	40 children enrolled
T6	Participants 1821 1841	children with autism
